Buprenorphine dispensing rates by state U.S. 2022

In 2022, the rate of buprenorphine prescriptions in the U.S. per 100 persons was 4.8. West Virginia had the highest buprenorphine dispensing rates at that time with just over 27 per 100 persons. Buprenorphine is used to treat opioid use disorder and has been seen by many as one effective way to combat the ongoing opioid epidemic in the United States. This statistic displays the rates of buprenorphine prescriptions dispensed in the United States in 2022, by state.

Buprenorphine dispensing rates in the United States in 2022, by state (per 100 persons)

Characteristic	Number of prescriptions per 100 persons
West Virginia	27.2
Vermont	25.5
Kentucky	23.6
Maine	17.8
Tennessee	10.9
Indiana	10.7
New Hampshire	10.7
Massachusetts	9.6
Pennsylvania	9.2
Rhode Island	8.7
Ohio	8.4
Alabama	7.3
Maryland	7
Delaware	6.8
North Dakota	6.5
Connecticut	6
North Carolina	5.7
Louisiana	5.6
Virginia	5.4
Alaska	5.3
Michigan	5.3
Washington	5.3
Oregon	5
Mississippi	4.8
Oklahoma	4.8
U.S. total	4.8
Arkansas	4.7
New Mexico	4.7
Idaho	4.5
New York	4.5
Utah	4.5
District Of Columbia	4.4
Montana	4.3
South Carolina	4.3
New Jersey	3.8
Wisconsin	3.7
Wyoming	3.1
Missouri	3
Florida	2.9
Arizona	2.8
Colorado	2.7
Minnesota	2.6
Nevada	2.4
Georgia	2.3
Illinois	2.2
Nebraska	2.1
South Dakota	2.1
Kansas	1.9
Hawaii	1.8
California	1.6
Texas	1.4
Iowa	1.3

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

May 2024

More information

Region

United States

Survey time period

2022

Supplementary notes

Data comes from IQVIA Xponent.

From the source: "IQVIA Xponent is based on a sample of approximately 56,500 retail (non-hospital) pharmacies, which dispense nearly 93% of all retail prescriptions in the United States. For this database, a prescription is a new or refilled prescription dispensed at a retail pharmacy in the sample and paid for by commercial insurance, Medicaid, Medicare, cash or its equivalent, and other third-party coverage. This database does not include mail-order prescriptions. Geographic location is based on the location of the prescriber. Methadone dispensed through methadone treatment programs is not included in the IQVIA Xponent data."

Citation formats